Global Voriconazole Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Voriconazole market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Voriconazole is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Voriconazole is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Voriconazole is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Voriconazole players cover Pfizer, Teva, GeneTech Pharm, Novartis, Mylan, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Voriconazole Industry Forecast” looks at past sales and reviews total world Voriconazole sales in 2024, providing a comprehensive analysis by region and market sector of projected Voriconazole sales for 2025 through 2031. With Voriconazole sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Voriconazole industry.
This Insight Report provides a comprehensive analysis of the global Voriconazole landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Voriconazole portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Voriconazole market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Voriconazole and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Voriconazole.
This report presents a comprehensive overview, market shares, and growth opportunities of Voriconazole market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Voriconazole market?
What factors are driving Voriconazole market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Voriconazole market opportunities vary by end market size?
How does Voriconazole break out by Type, by Application?
The global Voriconazole market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Voriconazole is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Voriconazole is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Voriconazole is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Voriconazole players cover Pfizer, Teva, GeneTech Pharm, Novartis, Mylan, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Voriconazole Industry Forecast” looks at past sales and reviews total world Voriconazole sales in 2024, providing a comprehensive analysis by region and market sector of projected Voriconazole sales for 2025 through 2031. With Voriconazole sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Voriconazole industry.
This Insight Report provides a comprehensive analysis of the global Voriconazole landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Voriconazole portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Voriconazole market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Voriconazole and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Voriconazole.
This report presents a comprehensive overview, market shares, and growth opportunities of Voriconazole market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Injection Voriconazole
- Voriconazole Freeze-dried Powder
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Teva
- GeneTech Pharm
- Novartis
- Mylan
- Squibb
- Sandoz
- Daiichi Sankyo
- GSK
- Cilag AG
- Macherey-Nagel GmbH
- Abbott
- Takeda
- Sichuan Beauty Sport Huakang Pharmaceutical
- Jincheng HEALTH Pharmaceutical
- Ebang Pharmaceutical
- Aditya Pharma
- Taj Pharmaceuticals
What is the 10-year outlook for the global Voriconazole market?
What factors are driving Voriconazole market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Voriconazole market opportunities vary by end market size?
How does Voriconazole break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Voriconazole Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Voriconazole by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Voriconazole by Country/Region, 2020, 2024 & 2031
2.2 Voriconazole Segment by Type
2.2.1 Injection Voriconazole
2.2.2 Voriconazole Freeze-dried Powder
2.3 Voriconazole Sales by Type
2.3.1 Global Voriconazole Sales Market Share by Type (2020-2025)
2.3.2 Global Voriconazole Revenue and Market Share by Type (2020-2025)
2.3.3 Global Voriconazole Sale Price by Type (2020-2025)
2.4 Voriconazole Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Voriconazole Sales by Application
2.5.1 Global Voriconazole Sale Market Share by Application (2020-2025)
2.5.2 Global Voriconazole Revenue and Market Share by Application (2020-2025)
2.5.3 Global Voriconazole Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Voriconazole Breakdown Data by Company
3.1.1 Global Voriconazole Annual Sales by Company (2020-2025)
3.1.2 Global Voriconazole Sales Market Share by Company (2020-2025)
3.2 Global Voriconazole Annual Revenue by Company (2020-2025)
3.2.1 Global Voriconazole Revenue by Company (2020-2025)
3.2.2 Global Voriconazole Revenue Market Share by Company (2020-2025)
3.3 Global Voriconazole Sale Price by Company
3.4 Key Manufacturers Voriconazole Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Voriconazole Product Location Distribution
3.4.2 Players Voriconazole Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VORICONAZOLE BY GEOGRAPHIC REGION
4.1 World Historic Voriconazole Market Size by Geographic Region (2020-2025)
4.1.1 Global Voriconazole Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Voriconazole Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Voriconazole Market Size by Country/Region (2020-2025)
4.2.1 Global Voriconazole Annual Sales by Country/Region (2020-2025)
4.2.2 Global Voriconazole Annual Revenue by Country/Region (2020-2025)
4.3 Americas Voriconazole Sales Growth
4.4 APAC Voriconazole Sales Growth
4.5 Europe Voriconazole Sales Growth
4.6 Middle East & Africa Voriconazole Sales Growth
5 AMERICAS
5.1 Americas Voriconazole Sales by Country
5.1.1 Americas Voriconazole Sales by Country (2020-2025)
5.1.2 Americas Voriconazole Revenue by Country (2020-2025)
5.2 Americas Voriconazole Sales by Type (2020-2025)
5.3 Americas Voriconazole Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Voriconazole Sales by Region
6.1.1 APAC Voriconazole Sales by Region (2020-2025)
6.1.2 APAC Voriconazole Revenue by Region (2020-2025)
6.2 APAC Voriconazole Sales by Type (2020-2025)
6.3 APAC Voriconazole Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Voriconazole by Country
7.1.1 Europe Voriconazole Sales by Country (2020-2025)
7.1.2 Europe Voriconazole Revenue by Country (2020-2025)
7.2 Europe Voriconazole Sales by Type (2020-2025)
7.3 Europe Voriconazole Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Voriconazole by Country
8.1.1 Middle East & Africa Voriconazole Sales by Country (2020-2025)
8.1.2 Middle East & Africa Voriconazole Revenue by Country (2020-2025)
8.2 Middle East & Africa Voriconazole Sales by Type (2020-2025)
8.3 Middle East & Africa Voriconazole Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Voriconazole
10.3 Manufacturing Process Analysis of Voriconazole
10.4 Industry Chain Structure of Voriconazole
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Voriconazole Distributors
11.3 Voriconazole Customer
12 WORLD FORECAST REVIEW FOR VORICONAZOLE BY GEOGRAPHIC REGION
12.1 Global Voriconazole Market Size Forecast by Region
12.1.1 Global Voriconazole Forecast by Region (2026-2031)
12.1.2 Global Voriconazole Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Voriconazole Forecast by Type (2026-2031)
12.7 Global Voriconazole Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Voriconazole Product Portfolios and Specifications
13.1.3 Pfizer Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Voriconazole Product Portfolios and Specifications
13.2.3 Teva Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 GeneTech Pharm
13.3.1 GeneTech Pharm Company Information
13.3.2 GeneTech Pharm Voriconazole Product Portfolios and Specifications
13.3.3 GeneTech Pharm Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 GeneTech Pharm Main Business Overview
13.3.5 GeneTech Pharm Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Voriconazole Product Portfolios and Specifications
13.4.3 Novartis Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Mylan
13.5.1 Mylan Company Information
13.5.2 Mylan Voriconazole Product Portfolios and Specifications
13.5.3 Mylan Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Mylan Main Business Overview
13.5.5 Mylan Latest Developments
13.6 Squibb
13.6.1 Squibb Company Information
13.6.2 Squibb Voriconazole Product Portfolios and Specifications
13.6.3 Squibb Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Squibb Main Business Overview
13.6.5 Squibb Latest Developments
13.7 Sandoz
13.7.1 Sandoz Company Information
13.7.2 Sandoz Voriconazole Product Portfolios and Specifications
13.7.3 Sandoz Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sandoz Main Business Overview
13.7.5 Sandoz Latest Developments
13.8 Daiichi Sankyo
13.8.1 Daiichi Sankyo Company Information
13.8.2 Daiichi Sankyo Voriconazole Product Portfolios and Specifications
13.8.3 Daiichi Sankyo Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Daiichi Sankyo Main Business Overview
13.8.5 Daiichi Sankyo Latest Developments
13.9 GSK
13.9.1 GSK Company Information
13.9.2 GSK Voriconazole Product Portfolios and Specifications
13.9.3 GSK Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 GSK Main Business Overview
13.9.5 GSK Latest Developments
13.10 Cilag AG
13.10.1 Cilag AG Company Information
13.10.2 Cilag AG Voriconazole Product Portfolios and Specifications
13.10.3 Cilag AG Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Cilag AG Main Business Overview
13.10.5 Cilag AG Latest Developments
13.11 Macherey-Nagel GmbH
13.11.1 Macherey-Nagel GmbH Company Information
13.11.2 Macherey-Nagel GmbH Voriconazole Product Portfolios and Specifications
13.11.3 Macherey-Nagel GmbH Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Macherey-Nagel GmbH Main Business Overview
13.11.5 Macherey-Nagel GmbH Latest Developments
13.12 Abbott
13.12.1 Abbott Company Information
13.12.2 Abbott Voriconazole Product Portfolios and Specifications
13.12.3 Abbott Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Abbott Main Business Overview
13.12.5 Abbott Latest Developments
13.13 Takeda
13.13.1 Takeda Company Information
13.13.2 Takeda Voriconazole Product Portfolios and Specifications
13.13.3 Takeda Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Takeda Main Business Overview
13.13.5 Takeda Latest Developments
13.14 Sichuan Beauty Sport Huakang Pharmaceutical
13.14.1 Sichuan Beauty Sport Huakang Pharmaceutical Company Information
13.14.2 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Product Portfolios and Specifications
13.14.3 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Sichuan Beauty Sport Huakang Pharmaceutical Main Business Overview
13.14.5 Sichuan Beauty Sport Huakang Pharmaceutical Latest Developments
13.15 Jincheng HEALTH Pharmaceutical
13.15.1 Jincheng HEALTH Pharmaceutical Company Information
13.15.2 Jincheng HEALTH Pharmaceutical Voriconazole Product Portfolios and Specifications
13.15.3 Jincheng HEALTH Pharmaceutical Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Jincheng HEALTH Pharmaceutical Main Business Overview
13.15.5 Jincheng HEALTH Pharmaceutical Latest Developments
13.16 Ebang Pharmaceutical
13.16.1 Ebang Pharmaceutical Company Information
13.16.2 Ebang Pharmaceutical Voriconazole Product Portfolios and Specifications
13.16.3 Ebang Pharmaceutical Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Ebang Pharmaceutical Main Business Overview
13.16.5 Ebang Pharmaceutical Latest Developments
13.17 Aditya Pharma
13.17.1 Aditya Pharma Company Information
13.17.2 Aditya Pharma Voriconazole Product Portfolios and Specifications
13.17.3 Aditya Pharma Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Aditya Pharma Main Business Overview
13.17.5 Aditya Pharma Latest Developments
13.18 Taj Pharmaceuticals
13.18.1 Taj Pharmaceuticals Company Information
13.18.2 Taj Pharmaceuticals Voriconazole Product Portfolios and Specifications
13.18.3 Taj Pharmaceuticals Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Taj Pharmaceuticals Main Business Overview
13.18.5 Taj Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Voriconazole Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Voriconazole Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injection Voriconazole
Table 4. Major Players of VoriconazoleFreeze-dried Powder
Table 5. Global Voriconazole Sales byType (2020-2025) & (K Pcs)
Table 6. Global Voriconazole Sales Market Share byType (2020-2025)
Table 7. Global Voriconazole Revenue byType (2020-2025) & ($ million)
Table 8. Global Voriconazole Revenue Market Share byType (2020-2025)
Table 9. Global Voriconazole Sale Price byType (2020-2025) & (USD/Pcs)
Table 10. Global Voriconazole Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Voriconazole Sale Market Share by Application (2020-2025)
Table 12. Global Voriconazole Revenue by Application (2020-2025) & ($ million)
Table 13. Global Voriconazole Revenue Market Share by Application (2020-2025)
Table 14. Global Voriconazole Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Voriconazole Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Voriconazole Sales Market Share by Company (2020-2025)
Table 17. Global Voriconazole Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Voriconazole Revenue Market Share by Company (2020-2025)
Table 19. Global Voriconazole Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Voriconazole Producing Area Distribution and Sales Area
Table 21. Players Voriconazole Products Offered
Table 22. Voriconazole Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Voriconazole Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Voriconazole Sales Market Share Geographic Region (2020-2025)
Table 27. Global Voriconazole Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Voriconazole Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Voriconazole Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Voriconazole Sales Market Share by Country/Region (2020-2025)
Table 31. Global Voriconazole Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Voriconazole Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Voriconazole Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Voriconazole Sales Market Share by Country (2020-2025)
Table 35. Americas Voriconazole Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Voriconazole Sales byType (2020-2025) & (K Pcs)
Table 37. Americas Voriconazole Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Voriconazole Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Voriconazole Sales Market Share by Region (2020-2025)
Table 40. APAC Voriconazole Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Voriconazole Sales byType (2020-2025) & (K Pcs)
Table 42. APAC Voriconazole Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Voriconazole Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Voriconazole Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Voriconazole Sales byType (2020-2025) & (K Pcs)
Table 46. Europe Voriconazole Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Voriconazole Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Voriconazole Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Voriconazole Sales byType (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Voriconazole Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Voriconazole
Table 52. Key Market Challenges & Risks of Voriconazole
Table 53. Key IndustryTrends of Voriconazole
Table 54. Voriconazole Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Voriconazole Distributors List
Table 57. Voriconazole Customer List
Table 58. Global Voriconazole SalesForecast by Region (2026-2031) & (K Pcs)
Table 59. Global Voriconazole RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Voriconazole SalesForecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Voriconazole Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Voriconazole SalesForecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Voriconazole Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Voriconazole SalesForecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Voriconazole RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Voriconazole SalesForecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Voriconazole RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Voriconazole SalesForecast byType (2026-2031) & (K Pcs)
Table 69. Global Voriconazole RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Voriconazole SalesForecast by Application (2026-2031) & (K Pcs)
Table 71. Global Voriconazole RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Pfizer Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer Voriconazole Product Portfolios and Specifications
Table 74. Pfizer Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77.Teva Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 78.Teva Voriconazole Product Portfolios and Specifications
Table 79.Teva Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 80.Teva Main Business
Table 81.Teva Latest Developments
Table 82. GeneTech Pharm Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 83. GeneTech Pharm Voriconazole Product Portfolios and Specifications
Table 84. GeneTech Pharm Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 85. GeneTech Pharm Main Business
Table 86. GeneTech Pharm Latest Developments
Table 87. Novartis Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 88. Novartis Voriconazole Product Portfolios and Specifications
Table 89. Novartis Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 90. Novartis Main Business
Table 91. Novartis Latest Developments
Table 92. Mylan Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 93. Mylan Voriconazole Product Portfolios and Specifications
Table 94. Mylan Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 95. Mylan Main Business
Table 96. Mylan Latest Developments
Table 97. Squibb Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 98. Squibb Voriconazole Product Portfolios and Specifications
Table 99. Squibb Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 100. Squibb Main Business
Table 101. Squibb Latest Developments
Table 102. Sandoz Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 103. Sandoz Voriconazole Product Portfolios and Specifications
Table 104. Sandoz Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 105. Sandoz Main Business
Table 106. Sandoz Latest Developments
Table 107. Daiichi Sankyo Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 108. Daiichi Sankyo Voriconazole Product Portfolios and Specifications
Table 109. Daiichi Sankyo Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 110. Daiichi Sankyo Main Business
Table 111. Daiichi Sankyo Latest Developments
Table 112. GSK Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 113. GSK Voriconazole Product Portfolios and Specifications
Table 114. GSK Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 115. GSK Main Business
Table 116. GSK Latest Developments
Table 117. Cilag AG Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 118. Cilag AG Voriconazole Product Portfolios and Specifications
Table 119. Cilag AG Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 120. Cilag AG Main Business
Table 121. Cilag AG Latest Developments
Table 122. Macherey-Nagel GmbH Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 123. Macherey-Nagel GmbH Voriconazole Product Portfolios and Specifications
Table 124. Macherey-Nagel GmbH Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 125. Macherey-Nagel GmbH Main Business
Table 126. Macherey-Nagel GmbH Latest Developments
Table 127. Abbott Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 128. Abbott Voriconazole Product Portfolios and Specifications
Table 129. Abbott Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 130. Abbott Main Business
Table 131. Abbott Latest Developments
Table 132.Takeda Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 133.Takeda Voriconazole Product Portfolios and Specifications
Table 134.Takeda Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 135.Takeda Main Business
Table 136.Takeda Latest Developments
Table 137. Sichuan Beauty Sport Huakang Pharmaceutical Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 138. Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Product Portfolios and Specifications
Table 139. Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 140. Sichuan Beauty Sport Huakang Pharmaceutical Main Business
Table 141. Sichuan Beauty Sport Huakang Pharmaceutical Latest Developments
Table 142. Jincheng HEALTH Pharmaceutical Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 143. Jincheng HEALTH Pharmaceutical Voriconazole Product Portfolios and Specifications
Table 144. Jincheng HEALTH Pharmaceutical Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 145. Jincheng HEALTH Pharmaceutical Main Business
Table 146. Jincheng HEALTH Pharmaceutical Latest Developments
Table 147. Ebang Pharmaceutical Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 148. Ebang Pharmaceutical Voriconazole Product Portfolios and Specifications
Table 149. Ebang Pharmaceutical Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 150. Ebang Pharmaceutical Main Business
Table 151. Ebang Pharmaceutical Latest Developments
Table 152. Aditya Pharma Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 153. Aditya Pharma Voriconazole Product Portfolios and Specifications
Table 154. Aditya Pharma Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 155. Aditya Pharma Main Business
Table 156. Aditya Pharma Latest Developments
Table 157.Taj Pharmaceuticals Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 158.Taj Pharmaceuticals Voriconazole Product Portfolios and Specifications
Table 159.Taj Pharmaceuticals Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 160.Taj Pharmaceuticals Main Business
Table 161.Taj Pharmaceuticals Latest Developments
LIST OFFIGURES
Figure 1. Picture of Voriconazole
Figure 2. Voriconazole Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Voriconazole Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Voriconazole Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Voriconazole Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Voriconazole Sales Market Share by Country/Region (2024)
Figure 10. Voriconazole Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Injection Voriconazole
Figure 12. Product Picture of VoriconazoleFreeze-dried Powder
Figure 13. Global Voriconazole Sales Market Share byType in 2025
Figure 14. Global Voriconazole Revenue Market Share byType (2020-2025)
Figure 15. Voriconazole Consumed in Hospital
Figure 16. Global Voriconazole Market: Hospital (2020-2025) & (K Pcs)
Figure 17. Voriconazole Consumed in Clinic
Figure 18. Global Voriconazole Market: Clinic (2020-2025) & (K Pcs)
Figure 19. Voriconazole Consumed in Other
Figure 20. Global Voriconazole Market: Other (2020-2025) & (K Pcs)
Figure 21. Global Voriconazole Sale Market Share by Application (2024)
Figure 22. Global Voriconazole Revenue Market Share by Application in 2025
Figure 23. Voriconazole Sales by Company in 2025 (K Pcs)
Figure 24. Global Voriconazole Sales Market Share by Company in 2025
Figure 25. Voriconazole Revenue by Company in 2025 ($ millions)
Figure 26. Global Voriconazole Revenue Market Share by Company in 2025
Figure 27. Global Voriconazole Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Voriconazole Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Voriconazole Sales 2020-2025 (K Pcs)
Figure 30. Americas Voriconazole Revenue 2020-2025 ($ millions)
Figure 31. APAC Voriconazole Sales 2020-2025 (K Pcs)
Figure 32. APAC Voriconazole Revenue 2020-2025 ($ millions)
Figure 33. Europe Voriconazole Sales 2020-2025 (K Pcs)
Figure 34. Europe Voriconazole Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Voriconazole Sales 2020-2025 (K Pcs)
Figure 36. Middle East & Africa Voriconazole Revenue 2020-2025 ($ millions)
Figure 37. Americas Voriconazole Sales Market Share by Country in 2025
Figure 38. Americas Voriconazole Revenue Market Share by Country (2020-2025)
Figure 39. Americas Voriconazole Sales Market Share byType (2020-2025)
Figure 40. Americas Voriconazole Sales Market Share by Application (2020-2025)
Figure 41. United States Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Voriconazole Sales Market Share by Region in 2025
Figure 46. APAC Voriconazole Revenue Market Share by Region (2020-2025)
Figure 47. APAC Voriconazole Sales Market Share byType (2020-2025)
Figure 48. APAC Voriconazole Sales Market Share by Application (2020-2025)
Figure 49. China Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 53. India Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Voriconazole Sales Market Share by Country in 2025
Figure 57. Europe Voriconazole Revenue Market Share by Country (2020-2025)
Figure 58. Europe Voriconazole Sales Market Share byType (2020-2025)
Figure 59. Europe Voriconazole Sales Market Share by Application (2020-2025)
Figure 60. Germany Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 61.France Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Voriconazole Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Voriconazole Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Voriconazole Sales Market Share by Application (2020-2025)
Figure 68. Egypt Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Voriconazole in 2025
Figure 74. Manufacturing Process Analysis of Voriconazole
Figure 75. Industry Chain Structure of Voriconazole
Figure 76. Channels of Distribution
Figure 77. Global Voriconazole Sales MarketForecast by Region (2026-2031)
Figure 78. Global Voriconazole Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Voriconazole Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Voriconazole Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Voriconazole Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Voriconazole Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Voriconazole Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Voriconazole by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Voriconazole by Country/Region, 2020, 2024 & 2031
2.2 Voriconazole Segment by Type
2.2.1 Injection Voriconazole
2.2.2 Voriconazole Freeze-dried Powder
2.3 Voriconazole Sales by Type
2.3.1 Global Voriconazole Sales Market Share by Type (2020-2025)
2.3.2 Global Voriconazole Revenue and Market Share by Type (2020-2025)
2.3.3 Global Voriconazole Sale Price by Type (2020-2025)
2.4 Voriconazole Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Voriconazole Sales by Application
2.5.1 Global Voriconazole Sale Market Share by Application (2020-2025)
2.5.2 Global Voriconazole Revenue and Market Share by Application (2020-2025)
2.5.3 Global Voriconazole Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Voriconazole Breakdown Data by Company
3.1.1 Global Voriconazole Annual Sales by Company (2020-2025)
3.1.2 Global Voriconazole Sales Market Share by Company (2020-2025)
3.2 Global Voriconazole Annual Revenue by Company (2020-2025)
3.2.1 Global Voriconazole Revenue by Company (2020-2025)
3.2.2 Global Voriconazole Revenue Market Share by Company (2020-2025)
3.3 Global Voriconazole Sale Price by Company
3.4 Key Manufacturers Voriconazole Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Voriconazole Product Location Distribution
3.4.2 Players Voriconazole Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VORICONAZOLE BY GEOGRAPHIC REGION
4.1 World Historic Voriconazole Market Size by Geographic Region (2020-2025)
4.1.1 Global Voriconazole Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Voriconazole Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Voriconazole Market Size by Country/Region (2020-2025)
4.2.1 Global Voriconazole Annual Sales by Country/Region (2020-2025)
4.2.2 Global Voriconazole Annual Revenue by Country/Region (2020-2025)
4.3 Americas Voriconazole Sales Growth
4.4 APAC Voriconazole Sales Growth
4.5 Europe Voriconazole Sales Growth
4.6 Middle East & Africa Voriconazole Sales Growth
5 AMERICAS
5.1 Americas Voriconazole Sales by Country
5.1.1 Americas Voriconazole Sales by Country (2020-2025)
5.1.2 Americas Voriconazole Revenue by Country (2020-2025)
5.2 Americas Voriconazole Sales by Type (2020-2025)
5.3 Americas Voriconazole Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Voriconazole Sales by Region
6.1.1 APAC Voriconazole Sales by Region (2020-2025)
6.1.2 APAC Voriconazole Revenue by Region (2020-2025)
6.2 APAC Voriconazole Sales by Type (2020-2025)
6.3 APAC Voriconazole Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Voriconazole by Country
7.1.1 Europe Voriconazole Sales by Country (2020-2025)
7.1.2 Europe Voriconazole Revenue by Country (2020-2025)
7.2 Europe Voriconazole Sales by Type (2020-2025)
7.3 Europe Voriconazole Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Voriconazole by Country
8.1.1 Middle East & Africa Voriconazole Sales by Country (2020-2025)
8.1.2 Middle East & Africa Voriconazole Revenue by Country (2020-2025)
8.2 Middle East & Africa Voriconazole Sales by Type (2020-2025)
8.3 Middle East & Africa Voriconazole Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Voriconazole
10.3 Manufacturing Process Analysis of Voriconazole
10.4 Industry Chain Structure of Voriconazole
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Voriconazole Distributors
11.3 Voriconazole Customer
12 WORLD FORECAST REVIEW FOR VORICONAZOLE BY GEOGRAPHIC REGION
12.1 Global Voriconazole Market Size Forecast by Region
12.1.1 Global Voriconazole Forecast by Region (2026-2031)
12.1.2 Global Voriconazole Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Voriconazole Forecast by Type (2026-2031)
12.7 Global Voriconazole Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Voriconazole Product Portfolios and Specifications
13.1.3 Pfizer Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Voriconazole Product Portfolios and Specifications
13.2.3 Teva Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 GeneTech Pharm
13.3.1 GeneTech Pharm Company Information
13.3.2 GeneTech Pharm Voriconazole Product Portfolios and Specifications
13.3.3 GeneTech Pharm Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 GeneTech Pharm Main Business Overview
13.3.5 GeneTech Pharm Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Voriconazole Product Portfolios and Specifications
13.4.3 Novartis Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Mylan
13.5.1 Mylan Company Information
13.5.2 Mylan Voriconazole Product Portfolios and Specifications
13.5.3 Mylan Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Mylan Main Business Overview
13.5.5 Mylan Latest Developments
13.6 Squibb
13.6.1 Squibb Company Information
13.6.2 Squibb Voriconazole Product Portfolios and Specifications
13.6.3 Squibb Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Squibb Main Business Overview
13.6.5 Squibb Latest Developments
13.7 Sandoz
13.7.1 Sandoz Company Information
13.7.2 Sandoz Voriconazole Product Portfolios and Specifications
13.7.3 Sandoz Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sandoz Main Business Overview
13.7.5 Sandoz Latest Developments
13.8 Daiichi Sankyo
13.8.1 Daiichi Sankyo Company Information
13.8.2 Daiichi Sankyo Voriconazole Product Portfolios and Specifications
13.8.3 Daiichi Sankyo Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Daiichi Sankyo Main Business Overview
13.8.5 Daiichi Sankyo Latest Developments
13.9 GSK
13.9.1 GSK Company Information
13.9.2 GSK Voriconazole Product Portfolios and Specifications
13.9.3 GSK Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 GSK Main Business Overview
13.9.5 GSK Latest Developments
13.10 Cilag AG
13.10.1 Cilag AG Company Information
13.10.2 Cilag AG Voriconazole Product Portfolios and Specifications
13.10.3 Cilag AG Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Cilag AG Main Business Overview
13.10.5 Cilag AG Latest Developments
13.11 Macherey-Nagel GmbH
13.11.1 Macherey-Nagel GmbH Company Information
13.11.2 Macherey-Nagel GmbH Voriconazole Product Portfolios and Specifications
13.11.3 Macherey-Nagel GmbH Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Macherey-Nagel GmbH Main Business Overview
13.11.5 Macherey-Nagel GmbH Latest Developments
13.12 Abbott
13.12.1 Abbott Company Information
13.12.2 Abbott Voriconazole Product Portfolios and Specifications
13.12.3 Abbott Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Abbott Main Business Overview
13.12.5 Abbott Latest Developments
13.13 Takeda
13.13.1 Takeda Company Information
13.13.2 Takeda Voriconazole Product Portfolios and Specifications
13.13.3 Takeda Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Takeda Main Business Overview
13.13.5 Takeda Latest Developments
13.14 Sichuan Beauty Sport Huakang Pharmaceutical
13.14.1 Sichuan Beauty Sport Huakang Pharmaceutical Company Information
13.14.2 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Product Portfolios and Specifications
13.14.3 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Sichuan Beauty Sport Huakang Pharmaceutical Main Business Overview
13.14.5 Sichuan Beauty Sport Huakang Pharmaceutical Latest Developments
13.15 Jincheng HEALTH Pharmaceutical
13.15.1 Jincheng HEALTH Pharmaceutical Company Information
13.15.2 Jincheng HEALTH Pharmaceutical Voriconazole Product Portfolios and Specifications
13.15.3 Jincheng HEALTH Pharmaceutical Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Jincheng HEALTH Pharmaceutical Main Business Overview
13.15.5 Jincheng HEALTH Pharmaceutical Latest Developments
13.16 Ebang Pharmaceutical
13.16.1 Ebang Pharmaceutical Company Information
13.16.2 Ebang Pharmaceutical Voriconazole Product Portfolios and Specifications
13.16.3 Ebang Pharmaceutical Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Ebang Pharmaceutical Main Business Overview
13.16.5 Ebang Pharmaceutical Latest Developments
13.17 Aditya Pharma
13.17.1 Aditya Pharma Company Information
13.17.2 Aditya Pharma Voriconazole Product Portfolios and Specifications
13.17.3 Aditya Pharma Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Aditya Pharma Main Business Overview
13.17.5 Aditya Pharma Latest Developments
13.18 Taj Pharmaceuticals
13.18.1 Taj Pharmaceuticals Company Information
13.18.2 Taj Pharmaceuticals Voriconazole Product Portfolios and Specifications
13.18.3 Taj Pharmaceuticals Voriconazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Taj Pharmaceuticals Main Business Overview
13.18.5 Taj Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Voriconazole Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Voriconazole Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injection Voriconazole
Table 4. Major Players of VoriconazoleFreeze-dried Powder
Table 5. Global Voriconazole Sales byType (2020-2025) & (K Pcs)
Table 6. Global Voriconazole Sales Market Share byType (2020-2025)
Table 7. Global Voriconazole Revenue byType (2020-2025) & ($ million)
Table 8. Global Voriconazole Revenue Market Share byType (2020-2025)
Table 9. Global Voriconazole Sale Price byType (2020-2025) & (USD/Pcs)
Table 10. Global Voriconazole Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Voriconazole Sale Market Share by Application (2020-2025)
Table 12. Global Voriconazole Revenue by Application (2020-2025) & ($ million)
Table 13. Global Voriconazole Revenue Market Share by Application (2020-2025)
Table 14. Global Voriconazole Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Voriconazole Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Voriconazole Sales Market Share by Company (2020-2025)
Table 17. Global Voriconazole Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Voriconazole Revenue Market Share by Company (2020-2025)
Table 19. Global Voriconazole Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Voriconazole Producing Area Distribution and Sales Area
Table 21. Players Voriconazole Products Offered
Table 22. Voriconazole Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Voriconazole Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Voriconazole Sales Market Share Geographic Region (2020-2025)
Table 27. Global Voriconazole Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Voriconazole Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Voriconazole Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Voriconazole Sales Market Share by Country/Region (2020-2025)
Table 31. Global Voriconazole Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Voriconazole Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Voriconazole Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Voriconazole Sales Market Share by Country (2020-2025)
Table 35. Americas Voriconazole Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Voriconazole Sales byType (2020-2025) & (K Pcs)
Table 37. Americas Voriconazole Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Voriconazole Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Voriconazole Sales Market Share by Region (2020-2025)
Table 40. APAC Voriconazole Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Voriconazole Sales byType (2020-2025) & (K Pcs)
Table 42. APAC Voriconazole Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Voriconazole Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Voriconazole Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Voriconazole Sales byType (2020-2025) & (K Pcs)
Table 46. Europe Voriconazole Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Voriconazole Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Voriconazole Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Voriconazole Sales byType (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Voriconazole Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Voriconazole
Table 52. Key Market Challenges & Risks of Voriconazole
Table 53. Key IndustryTrends of Voriconazole
Table 54. Voriconazole Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Voriconazole Distributors List
Table 57. Voriconazole Customer List
Table 58. Global Voriconazole SalesForecast by Region (2026-2031) & (K Pcs)
Table 59. Global Voriconazole RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Voriconazole SalesForecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Voriconazole Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Voriconazole SalesForecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Voriconazole Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Voriconazole SalesForecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Voriconazole RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Voriconazole SalesForecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Voriconazole RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Voriconazole SalesForecast byType (2026-2031) & (K Pcs)
Table 69. Global Voriconazole RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Voriconazole SalesForecast by Application (2026-2031) & (K Pcs)
Table 71. Global Voriconazole RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Pfizer Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer Voriconazole Product Portfolios and Specifications
Table 74. Pfizer Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77.Teva Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 78.Teva Voriconazole Product Portfolios and Specifications
Table 79.Teva Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 80.Teva Main Business
Table 81.Teva Latest Developments
Table 82. GeneTech Pharm Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 83. GeneTech Pharm Voriconazole Product Portfolios and Specifications
Table 84. GeneTech Pharm Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 85. GeneTech Pharm Main Business
Table 86. GeneTech Pharm Latest Developments
Table 87. Novartis Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 88. Novartis Voriconazole Product Portfolios and Specifications
Table 89. Novartis Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 90. Novartis Main Business
Table 91. Novartis Latest Developments
Table 92. Mylan Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 93. Mylan Voriconazole Product Portfolios and Specifications
Table 94. Mylan Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 95. Mylan Main Business
Table 96. Mylan Latest Developments
Table 97. Squibb Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 98. Squibb Voriconazole Product Portfolios and Specifications
Table 99. Squibb Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 100. Squibb Main Business
Table 101. Squibb Latest Developments
Table 102. Sandoz Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 103. Sandoz Voriconazole Product Portfolios and Specifications
Table 104. Sandoz Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 105. Sandoz Main Business
Table 106. Sandoz Latest Developments
Table 107. Daiichi Sankyo Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 108. Daiichi Sankyo Voriconazole Product Portfolios and Specifications
Table 109. Daiichi Sankyo Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 110. Daiichi Sankyo Main Business
Table 111. Daiichi Sankyo Latest Developments
Table 112. GSK Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 113. GSK Voriconazole Product Portfolios and Specifications
Table 114. GSK Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 115. GSK Main Business
Table 116. GSK Latest Developments
Table 117. Cilag AG Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 118. Cilag AG Voriconazole Product Portfolios and Specifications
Table 119. Cilag AG Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 120. Cilag AG Main Business
Table 121. Cilag AG Latest Developments
Table 122. Macherey-Nagel GmbH Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 123. Macherey-Nagel GmbH Voriconazole Product Portfolios and Specifications
Table 124. Macherey-Nagel GmbH Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 125. Macherey-Nagel GmbH Main Business
Table 126. Macherey-Nagel GmbH Latest Developments
Table 127. Abbott Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 128. Abbott Voriconazole Product Portfolios and Specifications
Table 129. Abbott Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 130. Abbott Main Business
Table 131. Abbott Latest Developments
Table 132.Takeda Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 133.Takeda Voriconazole Product Portfolios and Specifications
Table 134.Takeda Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 135.Takeda Main Business
Table 136.Takeda Latest Developments
Table 137. Sichuan Beauty Sport Huakang Pharmaceutical Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 138. Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Product Portfolios and Specifications
Table 139. Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 140. Sichuan Beauty Sport Huakang Pharmaceutical Main Business
Table 141. Sichuan Beauty Sport Huakang Pharmaceutical Latest Developments
Table 142. Jincheng HEALTH Pharmaceutical Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 143. Jincheng HEALTH Pharmaceutical Voriconazole Product Portfolios and Specifications
Table 144. Jincheng HEALTH Pharmaceutical Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 145. Jincheng HEALTH Pharmaceutical Main Business
Table 146. Jincheng HEALTH Pharmaceutical Latest Developments
Table 147. Ebang Pharmaceutical Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 148. Ebang Pharmaceutical Voriconazole Product Portfolios and Specifications
Table 149. Ebang Pharmaceutical Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 150. Ebang Pharmaceutical Main Business
Table 151. Ebang Pharmaceutical Latest Developments
Table 152. Aditya Pharma Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 153. Aditya Pharma Voriconazole Product Portfolios and Specifications
Table 154. Aditya Pharma Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 155. Aditya Pharma Main Business
Table 156. Aditya Pharma Latest Developments
Table 157.Taj Pharmaceuticals Basic Information, Voriconazole Manufacturing Base, Sales Area and Its Competitors
Table 158.Taj Pharmaceuticals Voriconazole Product Portfolios and Specifications
Table 159.Taj Pharmaceuticals Voriconazole Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 160.Taj Pharmaceuticals Main Business
Table 161.Taj Pharmaceuticals Latest Developments
LIST OFFIGURES
Figure 1. Picture of Voriconazole
Figure 2. Voriconazole Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Voriconazole Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Voriconazole Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Voriconazole Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Voriconazole Sales Market Share by Country/Region (2024)
Figure 10. Voriconazole Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Injection Voriconazole
Figure 12. Product Picture of VoriconazoleFreeze-dried Powder
Figure 13. Global Voriconazole Sales Market Share byType in 2025
Figure 14. Global Voriconazole Revenue Market Share byType (2020-2025)
Figure 15. Voriconazole Consumed in Hospital
Figure 16. Global Voriconazole Market: Hospital (2020-2025) & (K Pcs)
Figure 17. Voriconazole Consumed in Clinic
Figure 18. Global Voriconazole Market: Clinic (2020-2025) & (K Pcs)
Figure 19. Voriconazole Consumed in Other
Figure 20. Global Voriconazole Market: Other (2020-2025) & (K Pcs)
Figure 21. Global Voriconazole Sale Market Share by Application (2024)
Figure 22. Global Voriconazole Revenue Market Share by Application in 2025
Figure 23. Voriconazole Sales by Company in 2025 (K Pcs)
Figure 24. Global Voriconazole Sales Market Share by Company in 2025
Figure 25. Voriconazole Revenue by Company in 2025 ($ millions)
Figure 26. Global Voriconazole Revenue Market Share by Company in 2025
Figure 27. Global Voriconazole Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Voriconazole Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Voriconazole Sales 2020-2025 (K Pcs)
Figure 30. Americas Voriconazole Revenue 2020-2025 ($ millions)
Figure 31. APAC Voriconazole Sales 2020-2025 (K Pcs)
Figure 32. APAC Voriconazole Revenue 2020-2025 ($ millions)
Figure 33. Europe Voriconazole Sales 2020-2025 (K Pcs)
Figure 34. Europe Voriconazole Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Voriconazole Sales 2020-2025 (K Pcs)
Figure 36. Middle East & Africa Voriconazole Revenue 2020-2025 ($ millions)
Figure 37. Americas Voriconazole Sales Market Share by Country in 2025
Figure 38. Americas Voriconazole Revenue Market Share by Country (2020-2025)
Figure 39. Americas Voriconazole Sales Market Share byType (2020-2025)
Figure 40. Americas Voriconazole Sales Market Share by Application (2020-2025)
Figure 41. United States Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Voriconazole Sales Market Share by Region in 2025
Figure 46. APAC Voriconazole Revenue Market Share by Region (2020-2025)
Figure 47. APAC Voriconazole Sales Market Share byType (2020-2025)
Figure 48. APAC Voriconazole Sales Market Share by Application (2020-2025)
Figure 49. China Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 53. India Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Voriconazole Sales Market Share by Country in 2025
Figure 57. Europe Voriconazole Revenue Market Share by Country (2020-2025)
Figure 58. Europe Voriconazole Sales Market Share byType (2020-2025)
Figure 59. Europe Voriconazole Sales Market Share by Application (2020-2025)
Figure 60. Germany Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 61.France Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Voriconazole Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Voriconazole Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Voriconazole Sales Market Share by Application (2020-2025)
Figure 68. Egypt Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Voriconazole Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Voriconazole in 2025
Figure 74. Manufacturing Process Analysis of Voriconazole
Figure 75. Industry Chain Structure of Voriconazole
Figure 76. Channels of Distribution
Figure 77. Global Voriconazole Sales MarketForecast by Region (2026-2031)
Figure 78. Global Voriconazole Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Voriconazole Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Voriconazole Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Voriconazole Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Voriconazole Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Ophthalmology Homeopathic Products Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
92 pages
Global Urologic Endoscopy Market Growth 2023-2029
US$ 3,660.00
March 2023
102 pages
Global OTC Cough, Cold & Allergy Medicine Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
169 pages
Global Therapeutic Wearable Medical Devices Market Growth 2024-2030
US$ 3,660.00
December 2024
106 pages
Global Scabies Treatment Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
June 2024
110 pages
